PRURIGO NODULARIS (PN)
Clinical trials for PRURIGO NODULARIS (PN) explained in plain language.
Never miss a new study
Get alerted when new PRURIGO NODULARIS (PN) trials appear
Sign up with your email to follow new studies for PRURIGO NODULARIS (PN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New treatment tested for debilitating skin condition
Disease control Recruiting nowThis study aims to understand how well the drug dupilumab works over time for people with prurigo nodularis, a condition causing intensely itchy skin bumps. Researchers will follow 40 adults starting this treatment to measure itch relief, skin improvement, and side effects. They …
Matched conditions: PRURIGO NODULARIS (PN)
Sponsor: UMC Utrecht • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC
-
New pill aims to tame unbearable itch of skin disease
Symptom relief Recruiting nowThis study is testing whether an investigational oral drug called ICP-332 can safely reduce severe itching and improve skin lesions in people with prurigo nodularis, a chronic skin condition. About 135 adults who have not gotten enough relief from standard creams will receive eit…
Matched conditions: PRURIGO NODULARIS (PN)
Phase: PHASE2 • Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC